These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32107015)

  • 21. CircRNAs in diabetic cardiomyopathy.
    Wan H; Zhao S; Zeng Q; Tan Y; Zhang C; Liu L; Qu S
    Clin Chim Acta; 2021 Jun; 517():127-132. PubMed ID: 33711326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rare case of persistent troponin elevation in a patient with chronic heart failure.
    Cardoso G; Aguiar C; Ventosa A; Rebocho MJ; Borges Santos M; Dores H; Adragão P; Mendes M
    Rev Port Cardiol; 2013 Nov; 32(11):931-3. PubMed ID: 24239396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
    Jia G; Hill MA; Sowers JR
    Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for human diabetic cardiomyopathy.
    Marfella R; Sardu C; Mansueto G; Napoli C; Paolisso G
    Acta Diabetol; 2021 Aug; 58(8):983-988. PubMed ID: 33791873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic cardiomyopathy.
    Asghar O; Al-Sunni A; Khavandi K; Khavandi A; Withers S; Greenstein A; Heagerty AM; Malik RA
    Clin Sci (Lond); 2009 May; 116(10):741-60. PubMed ID: 19364331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current understanding of structural and molecular changes in diabetic cardiomyopathy.
    Akhtar MS; Alavudeen SS; Raza A; Imam MT; Almalki ZS; Tabassum F; Iqbal MJ
    Life Sci; 2023 Nov; 332():122087. PubMed ID: 37714373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PI3Kγ Inhibition Protects Against Diabetic Cardiomyopathy in Mice.
    Maffei A; Cifelli G; Carnevale R; Iacobucci R; Pallante F; Fardella V; Fardella S; Hirsch E; Lembo G; Carnevale D
    Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):16-24. PubMed ID: 27422446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids.
    Zhou Y; Suo W; Zhang X; Yang Y; Zhao W; Li H; Ni Q
    Biomed Pharmacother; 2023 Jan; 157():114025. PubMed ID: 36399824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in hypertrophic cardiomyopathy: What the cardiologist needs to know.
    Toste A
    Rev Port Cardiol; 2022 Jun; 41(6):499-509. PubMed ID: 36062694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures.
    Toedebusch R; Belenchia A; Pulakat L
    Front Physiol; 2018; 9():453. PubMed ID: 29773993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy.
    Veitch CR; Power AS; Erickson JR
    Front Pharmacol; 2021; 12():695401. PubMed ID: 34381362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic cardiomyopathy: prevalence, determinants and potential treatments.
    Gulsin GS; Athithan L; McCann GP
    Ther Adv Endocrinol Metab; 2019; 10():2042018819834869. PubMed ID: 30944723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on diabetic cardiomyopathy: inches forward, miles to go.
    Tillquist MN; Maddox TM
    Curr Diab Rep; 2012 Jun; 12(3):305-13. PubMed ID: 22528596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of diabetic cardiomyopathy.
    Bugger H; Abel ED
    Diabetologia; 2014 Apr; 57(4):660-71. PubMed ID: 24477973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NLRP3 inflammasome mechanism and therapeutic targets in diabetic cardiomyopathy.
    Sun Q; Guo W; Yue T; Wang L; Mou H
    Gac Med Mex; 2023; 159(3):255-261. PubMed ID: 37494725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic cardiomyopathy: Clinical phenotype and practice.
    Zhao X; Liu S; Wang X; Chen Y; Pang P; Yang Q; Lin J; Deng S; Wu S; Fan G; Wang B
    Front Endocrinol (Lausanne); 2022; 13():1032268. PubMed ID: 36568097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Updated Insight Into Molecular Mechanism of Hydrogen Sulfide in Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury Under Diabetes.
    Sun HJ; Wu ZY; Nie XW; Wang XY; Bian JS
    Front Pharmacol; 2021; 12():651884. PubMed ID: 34764865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diabetic cardiomyopathy: possible pathogenetic role of coronary microcirculation].
    Martinez R
    Minerva Cardioangiol; 1992; 40(1-2):1-5. PubMed ID: 1630665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic cardiomyopathy: an educational review.
    Xiao SL; Bober E; Kassianides X; Medici F; Xiao HB
    Br J Cardiol; 2023; 30(2):18. PubMed ID: 38911684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.